These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1619 related items for PubMed ID: 27210042
1. Genome Editing with CRISPR-Cas9: Can It Get Any Better? Haeussler M, Concordet JP. J Genet Genomics; 2016 May 20; 43(5):239-50. PubMed ID: 27210042 [Abstract] [Full Text] [Related]
2. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing. Yang ZX, Fu YW, Zhao JJ, Zhang F, Li SA, Zhao M, Wen W, Zhang L, Cheng T, Zhang JP, Zhang XB. Genomics Proteomics Bioinformatics; 2023 Dec 20; 21(6):1206-1220. PubMed ID: 36549468 [Abstract] [Full Text] [Related]
3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs. Yamamoto A, Ishida T, Yoshimura M, Kimura Y, Sawa S. Plant Cell Physiol; 2019 Oct 01; 60(10):2255-2262. PubMed ID: 31198958 [Abstract] [Full Text] [Related]
4. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention. Zhang Q, Xing HL, Wang ZP, Zhang HY, Yang F, Wang XC, Chen QJ. Plant Mol Biol; 2018 Mar 01; 96(4-5):445-456. PubMed ID: 29476306 [Abstract] [Full Text] [Related]
7. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells. Donohoue PD, Pacesa M, Lau E, Vidal B, Irby MJ, Nyer DB, Rotstein T, Banh L, Toh MS, Gibson J, Kohrs B, Baek K, Owen ALG, Slorach EM, van Overbeek M, Fuller CK, May AP, Jinek M, Cameron P. Mol Cell; 2021 Sep 02; 81(17):3637-3649.e5. PubMed ID: 34478654 [Abstract] [Full Text] [Related]
8. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing. Lee HJ, Kim HJ, Lee SJ. Int J Mol Sci; 2021 Jun 16; 22(12):. PubMed ID: 34208669 [Abstract] [Full Text] [Related]
9. [Design of Guide RNA for CRISPR/Cas Plant Genome Editing]. Gerashchenkov GA, Rozhnova NA, Kuluev BR, Kiryanova OY, Gumerova GR, Knyazev AV, Vershinina ZR, Mikhailova EV, Chemeris DA, Matniyazov RT, Baimiev AK, Gubaidullin IM, Baimiev AK, Chemeris AV. Mol Biol (Mosk); 2020 Jun 16; 54(1):29-50. PubMed ID: 32163387 [Abstract] [Full Text] [Related]
10. Chimeric DNA-RNA Guide RNA Designs. Lu S, Zhang Y, Yin H. Methods Mol Biol; 2021 Jun 16; 2162():79-85. PubMed ID: 32926379 [Abstract] [Full Text] [Related]
11. Prediction and Validation of Native and Engineered Cas9 Guide Sequences. Briner AE, Henriksen ED, Barrangou R. Cold Spring Harb Protoc; 2016 Jul 01; 2016(7):. PubMed ID: 27371591 [Abstract] [Full Text] [Related]
12. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing. Kelkar A, Zhu Y, Groth T, Stolfa G, Stablewski AB, Singhi N, Nemeth M, Neelamegham S. Mol Ther; 2020 Jan 08; 28(1):29-41. PubMed ID: 31601489 [Abstract] [Full Text] [Related]
14. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNAGln-processing system in human cells. He X, Wang Y, Yang F, Wang B, Xie H, Gu L, Zhao T, Liu X, Zhang D, Ren Q, Liu X, Liu Y, Gao C, Gu F. J Biol Chem; 2019 Jun 07; 294(23):9308-9315. PubMed ID: 31010827 [Abstract] [Full Text] [Related]
15. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences. Mekler V, Kuznedelov K, Severinov K. J Biol Chem; 2020 May 08; 295(19):6509-6517. PubMed ID: 32241913 [Abstract] [Full Text] [Related]
17. Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing. Kelley ML, Strezoska Ž, He K, Vermeulen A, Smith Av. J Biotechnol; 2016 Sep 10; 233():74-83. PubMed ID: 27374403 [Abstract] [Full Text] [Related]
18. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells. Yang Y, Li D, Wan F, Chen B, Wu G, Li F, Ren Y, Liang P, Wan J, Songyang Z. Cells; 2022 Nov 11; 11(22):. PubMed ID: 36429003 [Abstract] [Full Text] [Related]